SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-032997
Filing Date
2024-04-15
Accepted
2024-04-15 16:36:27
Documents
4
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea0203708-def14a_cerothera.htm DEF 14A 532586
2 GRAPHIC image_001.jpg GRAPHIC 3515
3 GRAPHIC image_002.jpg GRAPHIC 566631
4 GRAPHIC image_003.jpg GRAPHIC 359706
  Complete submission text file 0001213900-24-032997.txt   1814594
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40877 | Film No.: 24845112
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)